Cargando…

H3K27ac-activated lncRNA KTN1-AS1 aggravates tumor progression by miR-505-3p/ZNF326 axis in ovarian cancer

BACKGROUND: Numerous studies indicate that long noncoding RNA (lncRNA) is aberrantly expressed in ovarian cancer (OC). Our research investigated the regulatory role of lncRNA KTN1 antisense RNA1 (KTN1-AS1) in the progression of OC through the miR-505-3p/ZNF326 axis. METHODS: Expression of KTN1-AS1,...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Xiaohui, Wen, Qirong, Yang, Xu, Chen, Weiwei, Liu, Yaqiong, Liu, Wenjie, Zhang, Tiansong, Xu, Cuiyi, Shi, Kun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201172/
https://www.ncbi.nlm.nih.gov/pubmed/35722429
http://dx.doi.org/10.21037/atm-22-443
_version_ 1784728247095787520
author Xie, Xiaohui
Wen, Qirong
Yang, Xu
Chen, Weiwei
Liu, Yaqiong
Liu, Wenjie
Zhang, Tiansong
Xu, Cuiyi
Shi, Kun
author_facet Xie, Xiaohui
Wen, Qirong
Yang, Xu
Chen, Weiwei
Liu, Yaqiong
Liu, Wenjie
Zhang, Tiansong
Xu, Cuiyi
Shi, Kun
author_sort Xie, Xiaohui
collection PubMed
description BACKGROUND: Numerous studies indicate that long noncoding RNA (lncRNA) is aberrantly expressed in ovarian cancer (OC). Our research investigated the regulatory role of lncRNA KTN1 antisense RNA1 (KTN1-AS1) in the progression of OC through the miR-505-3p/ZNF326 axis. METHODS: Expression of KTN1-AS1, microRNA-505-3p (miR-505-3p), and zinc-finger protein-326 (ZNF326) in OC was evaluated by using RT-qPCR analysis. The biological function of KTN1-AS1 was inspected using the loss-of-function assay. Luciferase reporter assay and RIP assay were performed to determine the competitive endogenous RNA (ceRNA) network of KTN1-AS1/miR-505-3p/ZNF326. RESULTS: The data showed that KTN1-AS1 and ZNF326 had a high expression in OC than in the normal tissue, and miR-505-3p exhibited a low expression in OC than in the normal tissue. The knockdown of KTN1-AS1 caused an inhibition in OC cell proliferation, migration, and invasion, and promoted cell apoptosis. In terms of mechanical exploration, KTN1-AS1 was transcriptionally activated by histone H3 on lysine 27 acetylation (H3K27ac) at the promoter region, and KTN1-AS1 increased ZNF326 expression by competitively adsorbing miR-505-3p. CONCLUSIONS: This study indicated that H3K27ac-induced lncRNA KTN1-AS1 expression, and facilitated proliferation, migration, and invasion of OC cells by the KTN1-AS1/miR-505-3p/ZNF326 axis.
format Online
Article
Text
id pubmed-9201172
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-92011722022-06-17 H3K27ac-activated lncRNA KTN1-AS1 aggravates tumor progression by miR-505-3p/ZNF326 axis in ovarian cancer Xie, Xiaohui Wen, Qirong Yang, Xu Chen, Weiwei Liu, Yaqiong Liu, Wenjie Zhang, Tiansong Xu, Cuiyi Shi, Kun Ann Transl Med Original Article BACKGROUND: Numerous studies indicate that long noncoding RNA (lncRNA) is aberrantly expressed in ovarian cancer (OC). Our research investigated the regulatory role of lncRNA KTN1 antisense RNA1 (KTN1-AS1) in the progression of OC through the miR-505-3p/ZNF326 axis. METHODS: Expression of KTN1-AS1, microRNA-505-3p (miR-505-3p), and zinc-finger protein-326 (ZNF326) in OC was evaluated by using RT-qPCR analysis. The biological function of KTN1-AS1 was inspected using the loss-of-function assay. Luciferase reporter assay and RIP assay were performed to determine the competitive endogenous RNA (ceRNA) network of KTN1-AS1/miR-505-3p/ZNF326. RESULTS: The data showed that KTN1-AS1 and ZNF326 had a high expression in OC than in the normal tissue, and miR-505-3p exhibited a low expression in OC than in the normal tissue. The knockdown of KTN1-AS1 caused an inhibition in OC cell proliferation, migration, and invasion, and promoted cell apoptosis. In terms of mechanical exploration, KTN1-AS1 was transcriptionally activated by histone H3 on lysine 27 acetylation (H3K27ac) at the promoter region, and KTN1-AS1 increased ZNF326 expression by competitively adsorbing miR-505-3p. CONCLUSIONS: This study indicated that H3K27ac-induced lncRNA KTN1-AS1 expression, and facilitated proliferation, migration, and invasion of OC cells by the KTN1-AS1/miR-505-3p/ZNF326 axis. AME Publishing Company 2022-05 /pmc/articles/PMC9201172/ /pubmed/35722429 http://dx.doi.org/10.21037/atm-22-443 Text en 2022 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Xie, Xiaohui
Wen, Qirong
Yang, Xu
Chen, Weiwei
Liu, Yaqiong
Liu, Wenjie
Zhang, Tiansong
Xu, Cuiyi
Shi, Kun
H3K27ac-activated lncRNA KTN1-AS1 aggravates tumor progression by miR-505-3p/ZNF326 axis in ovarian cancer
title H3K27ac-activated lncRNA KTN1-AS1 aggravates tumor progression by miR-505-3p/ZNF326 axis in ovarian cancer
title_full H3K27ac-activated lncRNA KTN1-AS1 aggravates tumor progression by miR-505-3p/ZNF326 axis in ovarian cancer
title_fullStr H3K27ac-activated lncRNA KTN1-AS1 aggravates tumor progression by miR-505-3p/ZNF326 axis in ovarian cancer
title_full_unstemmed H3K27ac-activated lncRNA KTN1-AS1 aggravates tumor progression by miR-505-3p/ZNF326 axis in ovarian cancer
title_short H3K27ac-activated lncRNA KTN1-AS1 aggravates tumor progression by miR-505-3p/ZNF326 axis in ovarian cancer
title_sort h3k27ac-activated lncrna ktn1-as1 aggravates tumor progression by mir-505-3p/znf326 axis in ovarian cancer
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201172/
https://www.ncbi.nlm.nih.gov/pubmed/35722429
http://dx.doi.org/10.21037/atm-22-443
work_keys_str_mv AT xiexiaohui h3k27acactivatedlncrnaktn1as1aggravatestumorprogressionbymir5053pznf326axisinovariancancer
AT wenqirong h3k27acactivatedlncrnaktn1as1aggravatestumorprogressionbymir5053pznf326axisinovariancancer
AT yangxu h3k27acactivatedlncrnaktn1as1aggravatestumorprogressionbymir5053pznf326axisinovariancancer
AT chenweiwei h3k27acactivatedlncrnaktn1as1aggravatestumorprogressionbymir5053pznf326axisinovariancancer
AT liuyaqiong h3k27acactivatedlncrnaktn1as1aggravatestumorprogressionbymir5053pznf326axisinovariancancer
AT liuwenjie h3k27acactivatedlncrnaktn1as1aggravatestumorprogressionbymir5053pznf326axisinovariancancer
AT zhangtiansong h3k27acactivatedlncrnaktn1as1aggravatestumorprogressionbymir5053pznf326axisinovariancancer
AT xucuiyi h3k27acactivatedlncrnaktn1as1aggravatestumorprogressionbymir5053pznf326axisinovariancancer
AT shikun h3k27acactivatedlncrnaktn1as1aggravatestumorprogressionbymir5053pznf326axisinovariancancer